Correction to: Impact of 2021 ESC Guidelines for Cardiovascular Disease Prevention on Hypertensive Patients Risk: Secondary Analysis of Save Your Heart Study

被引：0
|
作者：
Rita Del Pinto
Corrado Giua
Enrico Keber
Eleonora Grippa
Marco Tilotta
Claudio Ferri
机构：
[1] University of L’Aquila,Department of Clinical Medicine, Public Health, Life and Environmental Sciences
[2] San Salvatore Hospital,Internal Medicine and Nephrology Unit, ESH Excellence Center for Hypertension and Cardiovascular Prevention
[3] Case Western Reserve University,Department of Pathology, School of Medicine
[4] Società Italiana Farmacia Clinica (SIFAC),undefined
[5] Medical Affairs,undefined
[6] Servier Italia,undefined
来源：
High Blood Pressure & Cardiovascular Prevention | 2023年 / 30卷 / 5期
关键词：
D O I：
10.1007/s40292-023-00599-w
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：487 / 487
相关论文
共 50 条
  • [11] SECONDARY PREVENTION IN HYPERTENSIVE PATIENTS WITH CORONARY HEART DISEASE
    Zhuravlyova, L.
    Filonenko, M.
    JOURNAL OF HYPERTENSION, 2015, 33 : E131 - E132
  • [12] SECONDARY PREVENTION IN HYPERTENSIVE PATIENTS WITH CORONARY HEART DISEASE
    Zivkovic, R.
    Lambic, L. J. Suric
    Zdravkovic, M.
    JOURNAL OF HYPERTENSION, 2015, 33 : E131 - E131
  • [13] Comments on the 2021 European Society of Cardiology (ESC) Guidelines on cardiovascular disease prevention in clinical practice
    Gielen, Stephan
    Wienbergen, Harm
    Reibis, Rona
    Koenig, Wolfgang
    Weil, Joachim
    Landmesser, Ulf
    KARDIOLOGIE, 2022, 16 (06): : 439 - 454
  • [14] Residual Risk of Cardiovascular Disease Among Patients Treated According to Guidelines for Secondary Prevention
    Nichols, Gregory A.
    Pedula, Kathryn L.
    Wang, Fang Q.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A380 - A380
  • [15] Global risk, statin eligibility and secondary coronary heart disease prevention in hypertensive patients
    Pedrinelli, R
    Omo, GD
    Buda, S
    Esposti, ED
    Mariani, M
    JOURNAL OF HYPERTENSION, 2003, 21 : S281 - S282
  • [16] 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Gaps in cardiovascular risk categories
    Torres-Conde, S.
    Buitrago-Ramirez, F.
    MEDICINA DE FAMILIA-SEMERGEN, 2025, 51 (03):
  • [17] The 2021 ESC/EACTS guidelines for the management of valvular heart disease: a new template for Heart Teams and their patients
    Prendergast, Bernard
    Vahanian, Alec
    CARDIOVASCULAR RESEARCH, 2022, 118 (01) : E11 - E13
  • [18] Management of heart failure in patients with kidney disease-updates from the 2021 ESC guidelines
    Edwards, Nicola C.
    Price, Anna M.
    Steeds, Richard P.
    Ferro, Charles J.
    Townend, Jonathan N.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (08) : 1798 - 1806
  • [19] Candesartan for cardiovascular prevention in Japanese hypertensive patients with coronary heart disease
    Staessen, Jan A.
    Richart, Tom
    Birkenhaeger, Willem H.
    EUROPEAN HEART JOURNAL, 2009, 30 (10) : 1164 - 1166
  • [20] Editorial: The 2021 European Society of Cardiology (ESC) Guidelines on the Real-World Prevention of Atherosclerotic Cardiovascular Disease (ASCVD)
    V. Parums, Dinah
    MEDICAL SCIENCE MONITOR, 2021, 27
12345